Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results

Benzinga11-11

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 400 points on Monday.

Following the market opening Monday, the Dow traded up 0.98% to 44,417.88 while the NASDAQ rose 0.18% to 19,321.30. The S&P 500 also rose, gaining, 0.32% to 6,014.50.

Check This Out: Top 4 Health Care Stocks That May Plunge This Quarter

Leading and Lagging SectorsConsumer discretionary shares surged by 1.9% on Monday.

In trading on Monday, information technology shares fell by 0.4%.

Top Headline

Shares of Monday.com Ltd (NASDAQ:MNDY) fell around 18% on Monday after the company reported results for its third quarter.

The company reported fiscal third-quarter 2024 revenue growth of 33% Y/Y to $251.0 million, beating the analyst consensus estimate of $246.1 million. The project management software company’s adjusted EPS of 85 cents beat the analyst consensus estimate of 63 cents.

Monday.com raised 2024 revenue guidance to $964 million–$966 million (prior $956 million–$961 million) against the consensus of $960.2 million and an adjusted operating margin of 12%–13% (prior 10%-11%)

Equities Trading UP                       

  • CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares shot up 190% to $0.2043 after the company announced the presentation of preclinical data demonstrating the capability of CER-1236 to kill ovarian cancer cells in preclinical models
  • Shares of FOXO Technologies Inc. (NYSE:FOXO) got a boost, surging 44% to $0.7149.
  • New Horizon Aircraft Ltd. (NYSE:HOVR) shares were also up, gaining 37% to $0.3969.

Equities Trading DOWN

  • 1847 Holdings LLC (NYSE:EFSH) shares dropped 46% to $1.96. 1847 Holdings signed a definitive agreement to acquire a cabinet, door & millwork manufacturer for $18.75 million.
  • Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) were down 38% to $1.80 after the company terminated its Zelnecirnon program following an FDA clinical hold due to a severe adverse event involving liver injury.
  • Nexalin Technology, Inc. (NASDAQ:NXL) was down, falling 30% to $2.65. Nexalin Technology's CEO issued a letter to shareholders.

CommoditiesIn commodity news, oil traded down 2.2% to $68.81 while gold traded down 1.2% at $2,661.90.

Silver traded down 0.8% to $31.19 on Monday, while copper fell 0.9% to $4.2690.

Euro zone

European shares were higher today. The eurozone's STOXX 600 gained 1.2%, Germany's DAX gained 1.4% and France's CAC 40 gained 1.2%. Spain's IBEX 35 Index rose 0.6%, while London's FTSE 100 rose 0.7%.

The BNP Paribas Real Estate Construction PMI in Ireland rose to 49.4 in October versus 49.0 in September,

Asia Pacific Markets

Asian markets closed mostly higher on Monday, with Japan's Nikkei 225 gaining 0.08%, Hong Kong's Hang Seng Index falling 1.45%, China's Shanghai Composite Index gaining 0.51% and India's BSE Sensex gaining 0.01%.

China's annual inflation rate was 0.3% in October compared to September's reading of 0.4%, while producer prices declined by 2.9% year-over-year in October. China’s vehicle sales climbed by 7% year-over-year to 3.05 million units in October compared to a 1.7% decline in the prior month.

The gauge for Japan's service sector fell to 47.5 in October compared to a revised reading of 47.8 in the prior month, while Japan's current account surplus fell to JPY 1,717.1 billion in September from JPY 2,954.2 billion in the year-ago month.

Economics

No major economic reports are scheduled for released today.

Now Read This:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment